Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms
This trial entry outlines a study on cognitive leisure and its neural mechanisms in preclinical Alzheimer's disease and is currently recruit…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Dementia in Migrants Living in Italy: Promoting a Diversity-sensitive Clinical Approach and Provision of Care
A clinical trial update focusing on dementia care among migrants in Italy, promoting a diversity-sensitive clinical approach and provision o…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment [NA]
This clinical trial update describes a study evaluating yeast-derived beta-glucan for potential cognitive benefits in mild cognitive impairm…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Noradrenergic Add-on Therapy With Guanfacine [Phase 3]
This entry notes a Phase 3 clinical trial evaluating guanfacine as an add-on therapy for Alzheimer's disease.
-
CLINICAL_TRIALS withdrawal · 2024-05-13Clinical Trial Update: WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease [NA]
A clinical trial evaluating a wearable neuromodulation device for Alzheimer's disease has been withdrawn. The study targeted mild Alzheimer'…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Treatment of Periodontal Disease in Patients With Alzheimer's Disease [NA]
A clinical trial is planned to evaluate periodontal treatment in patients with Alzheimer's disease; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease [Phase 1]
A Phase 1 trial evaluating a CSF1R inhibitor for Alzheimer's disease and mild cognitive impairment was terminated.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: The Effects of a Park Visit Program on Individuals With Dementia and Their Caregivers [NA]
This clinical trial update describes a study evaluating the effects of a park visit program on individuals with dementia and their caregiver…
-
FDA approval · 2024-05-08FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for rivastigmine filed by Sandoz Inc, resulting in an approved modification to the existing rivastig…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) [Phase 3]
A Phase 3 trial evaluating long-term gantenerumab in Alzheimer's disease has been terminated, and results are now posted.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) [NA]
This clinical trial in Castile and Leon, Spain completed a genetic study examining ApoE polymorphisms in individuals with Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients [NA]
A clinical trial update describing ongoing research on music lessons as an intervention to affect brain plasticity, mood, and quality of lif…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) [Phase 2]
Phase 2 clinical trial sponsored by the University of Virginia evaluating SHUTi MIND, an Internet-based program to address insomnia and asso…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
This document summarizes a tissue repository that provides annotated biospecimens for investigator-directed biomedical research, with ongoin…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
A clinical trial is evaluating LEQEMBI (lecanemab) for its effects on cerebral and retinal amyloid in individuals with Mild Cognitive Impair…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) [NA]
Clinical update announcing an extension to Cognito Therapeutics' pivotal sensory stimulation study in Alzheimer's disease, with enrollment b…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study to Evaluate XTR006 in Chinese Volunteers [Phase 1]
Phase 1 study evaluating XTR006 in Chinese volunteers with Alzheimer's disease has been completed.
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)
A Korean brain aging study (KBASE2) led by Seoul National University Hospital is currently recruiting participants to improve early diagnosi…
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) [Phase 1]
The first-in-human single ascending dose study of FluoroEthylNorMemantine (FENM) by ReST Therapeutics has been withdrawn; the listed conditi…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects [NA]
A completed clinical trial update reporting analysis of the XTR006 PET imaging agent across non-cognitively impaired individuals, mild cogni…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Turkish Speech Analysis Development Study
This clinical trial update describes an ongoing Turkish study on speech analysis development for Alzheimer's disease and mild cognitive impa…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
A Korean brain aging study assessing early diagnosis and prediction of Alzheimer's disease has completed. The study included participants wi…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating the potential of the Jiedu Yizhi Formula for Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017 [Phase 1]
Phase 1 single-ascending-dose study to evaluate the safety and tolerability of LY03017; the trial is not yet recruiting for indications incl…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Spatial Navigation for the Early Detection of Alzheimer's Disease. [NA]
A University Hospital Ghent clinical trial is exploring spatial navigation as a tool for early detection of Alzheimer's disease, enrolling i…